Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Alkabbani W, Pelletier R, Gamble JM. Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors and The Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events. Am J Epidemiol 2021 Mar 6. pii: 6159693. doi: 10.1093.
PMID: 33751032


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016